2018
DOI: 10.12688/f1000research.15663.1
|View full text |Cite
|
Sign up to set email alerts
|

Audit of transvaginal sonography of normal postmenopausal ovaries by sonographers from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Abstract: Background: We report on a unique audit of seven sonographers self-reporting high visualization rates of normal postmenopausal ovaries in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).  This audit was ordered by the trial’s Ultrasound Management Subcommittee after an initiative taken in 2008 to improve the quality of scanning and the subsequent increase in the number of sonographers claiming very high ovary visualisation rates. Methods: Seven sonographers reporting high rates (>8… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…The performance characteristics suggest that ultrasound as a first line test is not suitable for population ovarian cancer screening. The subjective nature of TVS, the challenges in identifying normal postmenopausal ovaries [ 8 ] that diminish in size with age and the low disease prevalence (1 in 2500) means that detection of disease early requires significant expertise coupled with constant attention to detail. In the course of the trial, we developed an accreditation programme for scanning postmenopausal ovaries [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The performance characteristics suggest that ultrasound as a first line test is not suitable for population ovarian cancer screening. The subjective nature of TVS, the challenges in identifying normal postmenopausal ovaries [ 8 ] that diminish in size with age and the low disease prevalence (1 in 2500) means that detection of disease early requires significant expertise coupled with constant attention to detail. In the course of the trial, we developed an accreditation programme for scanning postmenopausal ovaries [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…A key limitation relates to use of self-reported visualisation of postmenopausal ovaries as a quality assurance measure during the trial. A retrospective audit of random, grey scale TVS images showed only moderate agreement for visualisation of normal ovaries between experts and sonographers and between expert reviewers alone [ 8 ]. This was despite a robust accreditation programme established within the trial for visualisation of postmenopausal ovaries.…”
Section: Discussionmentioning
confidence: 99%